Open Access News

News from the open access movement


Tuesday, April 29, 2008

Open data and patient privacy in cancer genome research

The International Cancer Genome Consortium (ICGC) has released a major statement of its Goals, Structures, Policies, & Guidelines, April 2008.  (Thanks to Francis Ouellette.)  Excerpt:

...POLICY: To minimize the risk of patient/individual identification, the ICGC has established the policy that datasets be organized into two categories, open and controlled-access. Table 1 includes a list of data elements and the data access category within which they will be available.

The first category, Open Access Datasets, will be publicly accessible and contain only data that cannot be aggregated to generate a dataset unique to an individual. The second category, Controlled Access Datasets, will contain composite genomic and clinical data that are associated to a unique, but not directly identified, person....

An International Data Access Committee (IDAC) will be established as a policy-making group....

ICGC members will not have privileged access to data from other members of the Consortium. Rather, all data shared by the Consortium members will be obtained from the data that has been released to public databases.

Investigators outside of the ICGC are free to use data generated by ICGC members, either en masse or specific subsets, but are asked to follow the guidelines developed at the Ft. Lauderdale meeting. Specifically, data users should cite the source of the data and should acknowledge the clinical contributors and the data producers from the ICGC....

POLICY: All ICGC members agree not to make claims to possible IP derived from primary data (including somatic mutations) and to not pursue IP protections that would prevent or block access to or use of any element of ICGC data or conclusions drawn directly from those data....